France
BIOMODEX, founded in 2015 by Thomas Marchand and Sidarth Radjou, is a pioneering company in the Health Care, Medical Devices, and 3D Printing industries. Based in France, BIOMODEX leverages 3D printing to enhance physician training and offer patient-specific rehearsal solutions, reshaping pre-operative planning with its innovative, hands-on approach.
Operating from the Parisian technology incubator Agoranov, BIOMODEX’s mission is to provide advanced, customized training solutions for medical practitioners—bridging the gap between complex theory and practical application. Their slogan, "BIOMODEX® uses 3D printing for physician training and patient-specific rehearsal solutions founded in Paris," encapsulates this mission.
The company secured a $15.00M Series A investment on 08 June 2018, attracting investors such as IDInvest Partners, LBO France, WILCO, Inserm Transfert Initiative, and InnovAllianz. Positioned at the intersection of healthcare and technology, BIOMODEX presents a compelling opportunity for investors seeking innovation-driven growth.
